Biotechnology Research · Basel-Country
Basilea (SIX: BSLN) is a Swiss biopharmaceutical company, committed to discovering, developing and commercializing innovative drugs against infectious diseases. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. We are conducting clinical studies and have a number of preclinical assets in our portfolio. If you wish to become a part of a multinational, innovative team that strives to make a difference to patients’ outcomes worldwide, we would love to hear from you. Please use the link below to browse our current vacancies to see if we are currently offering a position that fits your profile and interests. Basilea has been recognized for its innovation and as an exceptional employer over the past years: 🏆 Innovation Awards: In both 2023 and 2024, Basilea was honored by the newspapers Bilanz and PME as one of Switzerland’s Top Innovative Companies. 🏆 Employer Recognition: In 2024, we were also awarded the title of a "Very Attractive Employer." These achievements reflect the dedication, creativity, and commitment of our incredible team. We are proud of these recognitions and extend our heartfelt thanks to all our employees for their loyalty and unwavering efforts every single day.